Long Noncoding RNA TP73-AS1 Targets MicroRNA-329-3p to Regulate Expression of the SMAD2 Gene in Human Cervical Cancer Tissue and Cell Lines.

CONCLUSIONS LncRNA TP73-AS1 promoted proliferation of cervical cancer cell lines by targeting miR-329-3p to regulate the expression of the SMAD2 gene. A regulatory network was formed between lncRNA TP73-AS1, miR-329-3p, and SMAD2. PMID: 31663517 [PubMed - in process]
Source: Medical Science Monitor - Category: Research Tags: Med Sci Monit Source Type: research

Related Links:

Source: Cancer Management and Research - Category: Cancer & Oncology Tags: Cancer Management and Research Source Type: research
Source: Clinical Interventions in Aging - Category: Geriatrics Tags: Clinical Interventions in Aging Source Type: research
Publication date: Available online 2 June 2020Source: Biochimica et Biophysica Acta (BBA) - Molecular Cell ResearchAuthor(s): Dipanwita Das Mukherjee, N. Maruthi Kumar, Mukund P. Tantak, Satabdi Datta, Debabrata Ghosh Dastidar, Dalip Kumar, Gopal Chakrabarti
Source: Biochimica et Biophysica Acta (BBA) Molecular Cell Research - Category: Molecular Biology Source Type: research
Conditions:   Cervical Carcinoma;   Human Papillomavirus Infection Interventions:   Other: Best Practice;   Procedure: HPV Self-Collection;   Other: Informational Intervention;   Other: Medical Chart Review;   Behavioral: Patient Navigation Program;   Other: Survey Administration Sponsors:   Ohio State University Comprehensive Cancer Center;   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
In conclusion, miR-204-5p/TFAP2A feedback loop promoted the proliferative and motorial capacities of cervical cancer cells. This finding suggested a novel modulatory loop of miR-204-5p/TFAP2A in cervical cancer, offering promising biomarkers for cervical cancer therapy. PMID: 32474464 [PubMed - as supplied by publisher]
Source: Cancer Biomarkers - Category: Cancer & Oncology Tags: Cancer Biomark Source Type: research
Condition:   Cervical Cancer Interventions:   Radiation: CCRT;   Drug: Paclitaxel, Cisplatin Sponsor:   Chongqing University Cancer Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
CONCLUSION: Many women do not have accurate knowledge of the new NCSP. Further health promotion in this area is warranted, where the general practitioner may play a key role. SO WHAT?: While the new NCSP will lead to further reduction in cervical cancer mortality, it appears from the data that women did not fully understand cervical cancer and its screening. This suggests the need for further health education to women about updated screening guidelines. PMID: 32475013 [PubMed - as supplied by publisher]
Source: Health Promotion Journal of Australia - Category: International Medicine & Public Health Tags: Health Promot J Austr Source Type: research
Condition:   Cervical Cancer Interventions:   Radiation: CCRT;   Drug: Paclitaxel, Cisplatin Sponsor:   Chongqing University Cancer Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
In the Netherlands, neoadjuvant chemoradiotherapy (nCRT) has become standard treatment for non-metastic resectable esophageal cancer as it increases survival compared to surgery alone. Stenosis of the cervical anastomosis is a common postoperative complication after gastric tube reconstruction requiring endoscopic dilations. We hypothesized that radiation dose on the future anastomotic region (FAR) was related to the occurrence and severity of the anastomotic stenosis. We evaluated the incidence of stenosis and analyzed risk factors associated with severity of the stenosis.
Source: Gastrointestinal Endoscopy - Category: Gastroenterology Authors: Tags: Poster abstracts Source Type: research
Future Microbiology, Ahead of Print.
Source: Future Microbiology - Category: Microbiology Authors: Source Type: research
More News: Biomedical Science | Cancer | Cancer & Oncology | Cervical Cancer | Genetics | Research | Science | Study | Women